US court shuts down AstraZeneca's challenge to Medicare drug price plan reut.rs/3EI2LUg
US court shuts down AstraZeneca's challenge to Medicare drug price plan
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the Medicare health insurance plan the power to negotiate lower drug prices.
reut.rs
May 8, 2025 at 6:10 PM
US court shuts down AstraZeneca's challenge to Medicare drug price plan reut.rs/3EI2LUg
Soriot should explain the curious case of AstraZeneca’s non-deal
Soriot should explain the curious case of AstraZeneca’s non-deal
AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders
www.theguardian.com
August 6, 2026 at 2:18 AM
Soriot should explain the curious case of AstraZeneca’s non-deal
Clinical trial underway for potential Long Covid treatment.
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
#LongCOVID
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
#LongCOVID
Clinical trial underway for potential Long Covid treatment - Schmidt Initiative for Long Covid
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatme...
silc.org
May 5, 2025 at 8:11 AM
Clinical trial underway for potential Long Covid treatment.
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
#LongCOVID
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
#LongCOVID
GOOD NEWS: An appeals court rejected AstraZeneca’s challenge to the constitutionality of the law we passed allowing Medicare to negotiate lower drug prices.
I led an amicus brief to the fighting back against this outrageous lawsuit. This decision is a win for patients!
I led an amicus brief to the fighting back against this outrageous lawsuit. This decision is a win for patients!
May 9, 2025 at 4:58 PM
GOOD NEWS: An appeals court rejected AstraZeneca’s challenge to the constitutionality of the law we passed allowing Medicare to negotiate lower drug prices.
I led an amicus brief to the fighting back against this outrageous lawsuit. This decision is a win for patients!
I led an amicus brief to the fighting back against this outrageous lawsuit. This decision is a win for patients!
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression reut.rs/3Sumhqn
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression
An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to AstraZeneca's Faslodex in patients with a specific gene mutation, according to trial results announced on Saturday.
reut.rs
May 31, 2025 at 1:40 PM
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression reut.rs/3Sumhqn
AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment reut.rs/3WLt4hs
AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment
AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer, according to data announced on Saturday.
reut.rs
October 18, 2025 at 2:40 PM
AstraZeneca's Enhertu shows promise in early-stage breast cancer treatment reut.rs/3WLt4hs
AstraZeneca announces new $820 million investment in Ontario www.bnnbloomberg.ca/business/com... @bloomberg.com
Get weekly updates: CanadaHealthwatch.ca/newsletter 🍁
Get weekly updates: CanadaHealthwatch.ca/newsletter 🍁
January 23, 2025 at 10:20 PM
AstraZeneca announces new $820 million investment in Ontario www.bnnbloomberg.ca/business/com... @bloomberg.com
Get weekly updates: CanadaHealthwatch.ca/newsletter 🍁
Get weekly updates: CanadaHealthwatch.ca/newsletter 🍁
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study reut.rs/3UZ2PXe
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study
AstraZeneca said on Tuesday its cancer drug, Imfinzi, combined with Amgen's targeted immunotherapy, Imdelltra, significantly improved overall survival of extensive-stage small-cell lung cancer patients in a late-stage trial.
reut.rs
September 8, 2026 at 6:30 PM
AstraZeneca's drug combo helps lung cancer patients live longer in late-stage study reut.rs/3UZ2PXe
EU regulator backs approval for AstraZeneca's experimental breast cancer pill reut.rs/4wG2zLj
EU regulator backs approval for AstraZeneca's experimental breast cancer pill
A European Medicines Agency committee on Friday backed approval for AstraZeneca's experimental breast cancer pill, camizestrant, differing from a U.S. regulatory panel's opinion about the drug.
reut.rs
May 22, 2026 at 3:45 PM
EU regulator backs approval for AstraZeneca's experimental breast cancer pill reut.rs/4wG2zLj
AstraZeneca’s FluMist, FDA-approved for at-home use, said Friday it is offering prescription home delivery in 34 states, including California. Here’s what to know.
Nasal spray flu vaccine can now be shipped to your home. Here’s how to get it
AstraZeneca’s FluMist, FDA-approved for at-home use, said Friday it is offering prescription home delivery in 34 states, including California. Here’s what to know.
bit.ly
August 15, 2025 at 11:40 PM
AstraZeneca’s FluMist, FDA-approved for at-home use, said Friday it is offering prescription home delivery in 34 states, including California. Here’s what to know.
The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.
www.statnews.com/2025/06/09/f...
www.statnews.com/2025/06/09/f...
Merck's RSV antibody treatment for infants is approved by FDA
The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.
www.statnews.com
June 9, 2025 at 10:53 PM
The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.
www.statnews.com/2025/06/09/f...
www.statnews.com/2025/06/09/f...
How investors killed AstraZeneca’s $400bn megadeal ft.trib.al/U0EfwfL
How investors killed AstraZeneca’s $400bn megadeal
Tie-up with US rival Bristol Myers would have marked return to big pharma mergers
ft.trib.al
August 11, 2026 at 5:01 PM
How investors killed AstraZeneca’s $400bn megadeal ft.trib.al/U0EfwfL
AstraZeneca’s U-turn on £450m Speke expansion ‘deeply disappointing’, says minister
AstraZeneca’s U-turn on £450m Speke expansion ‘deeply disappointing’, says minister
Chris Bryant says reduction of government support was linked to change in drugmaker’s proposed investment
* Nils Pratley: AstraZeneca’s £450m Speke U-turn looks terrible for a pro-growth government
The UK’s science minister, Chris Bryant, has…
www.theguardian.com
February 3, 2025 at 6:39 PM
AstraZeneca’s U-turn on £450m Speke expansion ‘deeply disappointing’, says minister
As global leaders meet to discuss efforts to address climate change, CFOs, too, face tough decisions around sustainability.
CFOs Weigh In as COP29, Trump’s Election Fuel Climate Debate
Plus, AstraZeneca’s Aradhana Sarin discusses margins, the Inflation Reduction Act and obesity drugs.
www.bloomberg.com
November 17, 2024 at 9:49 PM
As global leaders meet to discuss efforts to address climate change, CFOs, too, face tough decisions around sustainability.
AstraZeneca's Datroway extends survival in aggressive breast cancer reut.rs/48x6JLP
AstraZeneca's Datroway extends survival in aggressive breast cancer
AstraZeneca and Daiichi Sankyo's new breast cancer drug helped significantly extend survival in some patients in a late-stage trial, marking a potential breakthrough in one of the hardest-to-treat forms of the disease.
reut.rs
October 19, 2025 at 7:05 AM
AstraZeneca's Datroway extends survival in aggressive breast cancer reut.rs/48x6JLP
Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London | Nils Pratley
Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London | Nils Pratley
One hopes cogs are turning in Westminster after Pascal Soriot’s affectionate talk of US at pharmaceutical giant’s half-year results
www.theguardian.com
July 29, 2025 at 6:37 PM
Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London | Nils Pratley
AstraZeneca’s £450m Speke U-turn looks terrible for a pro-growth government | Nils Pratley
AstraZeneca’s £450m Speke U-turn looks terrible for a pro-growth government | Nils Pratley
It seems bizarre that ministers and UK’s largest company cannot complete investment in vital life sciences sector
The announcement in March last year that AstraZeneca would be investing £450m to expand its vaccine plant in Speke in Liverpool was…
www.theguardian.com
February 3, 2025 at 4:57 PM
AstraZeneca’s £450m Speke U-turn looks terrible for a pro-growth government | Nils Pratley
China has trapped the tiger of AstraZeneca’s growth
https://www.ft.com/content/bdfe878d-0165-4267-bb95-5da22c2095b0
https://www.ft.com/content/bdfe878d-0165-4267-bb95-5da22c2095b0
China has trapped the tiger of AstraZeneca’s growth
The UK pharmaceutical company needs to resolve a corruption crackdown affecting senior executives
www.ft.com
November 14, 2024 at 5:17 AM
China has trapped the tiger of AstraZeneca’s growth
https://www.ft.com/content/bdfe878d-0165-4267-bb95-5da22c2095b0
https://www.ft.com/content/bdfe878d-0165-4267-bb95-5da22c2095b0
It was Bernie Sanders and the Senate HELP Committee' investigation into Big Pharma's deadly price gouging that led to AstraZeneca's $35 inhaler cap. Other companies must follow.
March 20, 2024 at 1:46 PM
It was Bernie Sanders and the Senate HELP Committee' investigation into Big Pharma's deadly price gouging that led to AstraZeneca's $35 inhaler cap. Other companies must follow.
AstraZeneca's blood pressure drug wins U.S. approval reut.rs/4fbWxfd
AstraZeneca's blood pressure drug wins U.S. approval
Anglo-Swedish drugmaker AstraZeneca said on Monday its hypertension pill baxdrostat had been approved in the United States, offering a new treatment option for millions of patients with uncontrolled high blood pressure despite existing medicines.
reut.rs
May 18, 2026 at 6:05 AM
AstraZeneca's blood pressure drug wins U.S. approval reut.rs/4fbWxfd
AstraZeneca's Datroway boosts survival in advanced breast cancer trial reut.rs/4nVhxZb
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
AstraZeneca said on Monday its precision drug Datroway improved overall survival and progression free survival in patients with an advanced form of breast cancer versus chemotherapy in a trial when given early during treatment.
reut.rs
October 6, 2025 at 7:00 AM
AstraZeneca's Datroway boosts survival in advanced breast cancer trial reut.rs/4nVhxZb
AstraZeneca's immune disorder drug succeeds in late-stage trial reut.rs/46lHk6L
AstraZeneca's immune disorder drug succeeds in late-stage trial
AstraZeneca said on Thursday its experimental therapy gefurulimab met the main goal of a late-stage study looking into improving symptoms of a chronic, autoimmune condition known as generalised myasthenia gravis in adults.
reut.rs
July 24, 2025 at 7:35 AM
AstraZeneca's immune disorder drug succeeds in late-stage trial reut.rs/46lHk6L
AstraZeneca's Breztri meets main goals of late-stage asthma trials reut.rs/44lMzlQ
AstraZeneca's Breztri meets main goals of late-stage asthma trials
Anglo-Swedish drugmaker AstraZeneca on Friday said its inhaler therapy Breztri Aerosphere met all the main goals of two late-stage trials in patients with uncontrolled asthma.
reut.rs
May 2, 2025 at 6:40 AM
AstraZeneca's Breztri meets main goals of late-stage asthma trials reut.rs/44lMzlQ
Ok, I know promised a thread on the fascinating and important new research explaining what happened with the rare, serious side effects of AstraZeneca's and Johnson&Johnson's Covid-19 vaccines.
So, @science.org story is here and 🧪🧵 is coming:
www.science.org/content/arti...
So, @science.org story is here and 🧪🧵 is coming:
www.science.org/content/arti...
Rare, dangerous side effects of some COVID-19 vaccines explained
“Groundbreaking” study uncovers why adenovirus-based shots caused life-threatening blood clots and bleeding in some people
www.science.org
February 12, 2026 at 8:28 PM
Ok, I know promised a thread on the fascinating and important new research explaining what happened with the rare, serious side effects of AstraZeneca's and Johnson&Johnson's Covid-19 vaccines.
So, @science.org story is here and 🧪🧵 is coming:
www.science.org/content/arti...
So, @science.org story is here and 🧪🧵 is coming:
www.science.org/content/arti...
An investigation published by The BMJ raised concerns over the 15 years' old landmark PLATO that was used to gain worldwide approval for AstraZeneca's anti-platelet drug ticagrelor (Brilinta in 🇺🇸)
December 22, 2024 at 3:50 AM
An investigation published by The BMJ raised concerns over the 15 years' old landmark PLATO that was used to gain worldwide approval for AstraZeneca's anti-platelet drug ticagrelor (Brilinta in 🇺🇸)